Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world multicenter registry study of Jingfukang Granules for cervical spondylosis
ChiCTR1900023298Phase 4Completed
- Sponsor
- Fujian Academy of Traditional Chinese Medicine
- Start
- Jun 2019
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Jingfukang Granule in cervical osteoarthritis, sponsored by Fujian Academy of Traditional Chinese Medicine. Primary endpoint: Visual analogue scale. Started Jun 2019; status: completed.
02
Drugs
Jingfukang Granule
03
Conditions
cervical osteoarthritis
Beyond the preview
Go deeper on ChiCTR1900023298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023298.